170 related articles for article (PubMed ID: 3562057)
1. The correlation between delayed hypersensitivity, lymphocyte activation and protective immunity in experimental murine leishmaniasis.
De Rossell RA; Bray RS; Alexander J
Parasite Immunol; 1987 Jan; 9(1):105-15. PubMed ID: 3562057
[TBL] [Abstract][Full Text] [Related]
2. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
Alexander J; Kaye PM
Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
[TBL] [Abstract][Full Text] [Related]
3. Induction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.
Dhaliwal JS; Liew FY
Infect Immun; 1987 Mar; 55(3):645-51. PubMed ID: 3818088
[TBL] [Abstract][Full Text] [Related]
4. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
Rosas LE; Keiser T; Barbi J; Satoskar AA; Septer A; Kaczmarek J; Lezama-Davila CM; Satoskar AR
Int Immunol; 2005 Oct; 17(10):1347-57. PubMed ID: 16141242
[TBL] [Abstract][Full Text] [Related]
5. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
Sadick MD; Locksley RM; Tubbs C; Raff HV
J Immunol; 1986 Jan; 136(2):655-61. PubMed ID: 3079789
[TBL] [Abstract][Full Text] [Related]
6. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
Scott P; Pearce E; Natovitz P; Sher A
J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
[TBL] [Abstract][Full Text] [Related]
7. [Activation of suppressor cells of the delayed hypersensitivity response in BALB/c mice infected or immunized with Leishmania mexicana pifanoi].
Pérez HA; Henriquez M; de la Rosa M
Mem Inst Oswaldo Cruz; 1985; 80(4):429-38. PubMed ID: 2943969
[TBL] [Abstract][Full Text] [Related]
8. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
Müller I; Pedrazzini T; Kropf P; Louis J; Milon G
Int Immunol; 1991 Jun; 3(6):587-97. PubMed ID: 1909563
[TBL] [Abstract][Full Text] [Related]
9. Leishmania tropica infection, in comparison to Leishmania major, induces lower delayed type hypersensitivity in BALB/c mice.
Mahmoudzadeh-Niknam H; Kiaei SS; Iravani D
Korean J Parasitol; 2007 Jun; 45(2):103-9. PubMed ID: 17570972
[TBL] [Abstract][Full Text] [Related]
10. Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major.
Alexander J
Parasitology; 1988 Apr; 96 ( Pt 2)():297-302. PubMed ID: 3374966
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.
Yang DM; Rogers MV; Liew FY
Immunology; 1991 Jan; 72(1):3-9. PubMed ID: 1997399
[TBL] [Abstract][Full Text] [Related]
12. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.
Howard JG; Hale C; Liew FY
J Exp Med; 1980 Sep; 152(3):594-607. PubMed ID: 6447751
[TBL] [Abstract][Full Text] [Related]
13. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility to murine cutaneous leishmaniasis correlates with the capacity to generate interleukin 3 in response to leishmania antigen in vitro.
Lelchuk R; Graveley R; Liew FY
Cell Immunol; 1988 Jan; 111(1):66-76. PubMed ID: 3257416
[TBL] [Abstract][Full Text] [Related]
15. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
Liew FY; Dhaliwal JS
J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
[TBL] [Abstract][Full Text] [Related]
16. [Determination of the specificity of seric IgA produced in response to antigens of Leishmania (Leishmania) mexicana in murine leishmaniasis].
Pérez-Aguilar MC; Hernández O; Maizo de Segnini Z; Rojas CH; Díaz S; Alarcón M; Goncalves L
Invest Clin; 2011 Sep; 52(3):216-29. PubMed ID: 21950193
[TBL] [Abstract][Full Text] [Related]
17. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
Torrentera FA; Glaichenhaus N; Laman JD; Carlier Y
Infect Immun; 2001 Jan; 69(1):617-21. PubMed ID: 11119565
[TBL] [Abstract][Full Text] [Related]
18. New Zealand black mice are immunologically resistant to high-dose, but not low-dose Leishmania mexicana infection.
Dorea RC; Alexander J; Gallagher G
Clin Exp Immunol; 1991 Aug; 85(2):231-5. PubMed ID: 1864002
[TBL] [Abstract][Full Text] [Related]
19. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
Liew FY; Hale C; Howard JG
J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
[TBL] [Abstract][Full Text] [Related]
20. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages.
Handman E; Ceredig R; Mitchell GF
Aust J Exp Biol Med Sci; 1979 Feb; 57(1):9-29. PubMed ID: 314286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
